NEO Stock Analysis: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$16.98
0.45 (2.72%)
▲
5d:
+6.52%
30d:
+19.24%
90d:
+86.39%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NEO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NEO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.73
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $16.98, which is considered extended relative to its 30-day fair value range of $14.22 to $16.35. From a valuation perspective, the stock is trading at a premium (Forward PE: 49.4) compared to its historical average (41.7). At these levels, the market is pricing in 5.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NEO is in a strong uptrend. The price is approaching resistance at $17.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.72 (+16.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NEO is in a strong uptrend. The price is approaching resistance at $17.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.72 (+16.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.22 -
$16.35
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding NEO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.72)
- NEUTRAL: PE elevated vs history but 5.8% growth expectation is conservative given 131% recent growth
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$14.22 -
$16.35
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.72
Resistance Level
$17.08
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
49.42
Wall Street Target
$19.72
(+16.1%)
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
130.6%
Profit Margin
-6.8%
Valuation Premium vs History
+5.8% premium
PE vs Historical
49.4 vs 41.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.8%
(market-implied from PE analysis)
1-Year Target
$17.96
(+6%)
2-Year Target
$19.01
(+12%)
3-Year Target
$20.11
(+18%)
3-Yr Target (if PE normalizes)
(PE: 49→42)
PE COMPRESSION
$16.97
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 49.4, Growth: 89.9%)
$57.31
(+238%)
Base:
(SPY PE: 20.1, Growth: 89.9%)
$23.27
(+37%)
Bear:
(PE: 17.1, Growth: 89.9%)
$19.78
(+17%)
Share & Embed Analysis
Last updated: August 23, 2026 12:56 AM ET
Data refreshes hourly during market hours. Next update: 1:56 AM
Data refreshes hourly during market hours. Next update: 1:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
Advanced NEO Option Strategies
Professional options setups generated by AI based on today's NEO price and gamma walls.
